4,614 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Finding Value In Dividend Stocks (Part 1): Setting Up A Plan To Take Advantage Of The Correction http://seekingalpha.com/article/3460616-finding-value-in-dividend-stocks-part-1-setting-up-a-plan-to-take-advantage-of-the-correction?source=feed Aug 24, 2015 - The current sell-off has already presented some fantastic opportunities in some great high-quality dividend stocks.
IPO Lockup Expiration: Entellus Medical http://seekingalpha.com/article/3458056-ipo-lockup-expiration-entellus-medical?source=feed_tag_ipo_analysis Aug 22, 2015 - August 24, 2015 ends the 180-day lockup period on ENTL.
Retirement Strategy: When There Is Blood In The Streets, Will You Become A Vampire? http://seekingalpha.com/article/3459126-retirement-strategy-when-there-is-blood-in-the-streets-will-you-become-a-vampire?source=feed Aug 21, 2015 - There are plenty of stocks for DGIers to start looking at.
Foot Locker's (FL) CEO Dick Johnson on Q2 2015 Results - Earnings Call Transcript http://seekingalpha.com/article/3458926-foot-lockers-fl-ceo-dick-johnson-on-q2-2015-results-earnings-call-transcript?source=feed_tag_transcripts Aug 21, 2015 - Foot Locker, Inc. (NYSE:FL) Q2 2015 Earnings Conference Call August 21, 2015 09:00 AM ET Executives John Maurer - IR Dick Johnson - CEO Lauren Peters - CFO Analysts Camilo Lyon - Canaccord Genuity Sco
AptarGroup: The Leader in Dispensing Innovation http://www.gurufocus.com/news/354918/aptargroup-the-leader-in-dispensing-innovation Aug 21, 2015 - AptarGroup: The Leader in Dispensing Innovation, Stocks: ATR,JNJ,PG,GSK,KRFT,PEP,UL, release date:Aug 21, 2015
Why Four Months Is Worth $350m To AbbVie And Filgotinib http://seekingalpha.com/article/3458516-why-four-months-is-worth-350m-to-abbvie-and-filgotinib?source=feed_sector_healthcare Aug 21, 2015 - AbbVie’s (NYSE:ABBV) $350m cheque to United Therapeutics (NASDAQ:UTHR) for a priority review voucher ought to pique observers’ curiosity about which of its pipeline assets is worth acceler
Premarket Biotech Digest: Jimmy Carter And Keytruda, Geron Buying Op, Valeant-Sprout http://seekingalpha.com/article/3457566-premarket-biotech-digest-jimmy-carter-and-keytruda-geron-buying-op-valeant-sprout?source=feed_sector_healthcare Aug 21, 2015 - Jimmy Carter is taking Keytruda, Merck's anti-PD-1 receptor drug for melanoma.
Valeant Pharmaceuticals' New Female Drug http://www.gurufocus.com/news/354599/valeant-pharmaceuticals-new-female-drug Aug 20, 2015 - Valeant Pharmaceuticals' New Female Drug, Stocks: VRX,NVS,JNJ,APD,CP, Bill Ackman,Kyle Bass,Ken Fisher,Steven Cohen,Geor, release date:Aug 20, 2015
A Review Of Gilead's Pipeline (Part 2): Focus On Zydelig And Lymphoma/CLL Candidates http://seekingalpha.com/article/3454586-a-review-of-gileads-pipeline-part-2-focus-on-zydelig-and-lymphoma-cll-candidates?source=feed_sector_healthcare Aug 20, 2015 - Gilead is making a large effort in oncology and related fields.
Dividend Investors Should Consider Johnson & Johnson http://www.gurufocus.com/news/354245/dividend-investors-should-consider-johnson--johnson Aug 19, 2015 - Dividend Investors Should Consider Johnson & Johnson, Stocks: JNJ,GILD,ABBV, release date:Aug 19, 2015

Pages: 1...456457458459460461462

<<<Page 461